Difference between revisions of "User:Shawndouglas/sandbox/sublevel4"

From LIMSWiki
Jump to navigationJump to search
Tag: Reverted
 
(95 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Infobox company
<div class="nonumtoc">__TOC__</div>
|company_name      =  '''LabLynx, Inc.'''
{{ombox
|company_logo      =  [[File:Official 2022 lablynx logo.png|220px]]
| type      = notice
|company_type      =  Incorporated
| style     = width: 960px;
|traded_as        =
| text      = This is sublevel4 of my sandbox, where I play with features and test MediaWiki code. If you wish to leave a comment for me, please see [[User_talk:Shawndouglas|my discussion page]] instead.<p></p>
|industry          =  [[Laboratory informatics]]
|genre            =
|fate              =
|predecessor      =
|successor        =
|company_slogan    = 
|foundation        =  July 24, 2000<ref name="SoS_llx">{{cite web |url=https://ecorp.sos.ga.gov/BusinessSearch/BusinessInformation?businessId=33586 |title=Business Entity – LabLynx, Inc. |publisher=Georgia Secretary of State |accessdate=29 December 2015}}</ref>
|founder          =  [[LabLynx KB:John H. Jones|John H. Jones]]
|defunct          =
|location_city     = 2400 Lake Park Drive<br />Suite 435<br />Smyrna, Georgia 30080
|location_country  =  U.S.<br />1-866-LABLYNX
|locations        = 
|area_served      =  Worldwide
|key_people        = 
|products          =  {{Collapsible list
  |framestyle=border:none; padding:0;
  |title=<small>Products list</small>
  |1=<li>ELab
  |2=<li>ELab LIMS for Cannabis
  |3=<li>HealthCloud POL
  |4=<li>LabVia
  |5=<li>webLIMS}}
|production        =
|service          =
|revenue          =  ~ $2 million<ref name="Owler">{{cite web |url=https://www.owler.com/company/lablynx |title=LabLynx, Inc. |publisher=Owler, Inc |accessdate=28 October 2020}}</ref>
|operating_income  = 
|net_income        = 
|aum              =
|assets            = 
|equity            =
|owner            = 
|num_employees    =  40+<ref name="Owler" />
|parent            = 
|divisions        =
|subsid            = 
|homepage          =  {{URL|https://www.lablynx.com/|LabLynx.com}}<br />{{URL|https://www.cannaqa.com/|CannaQA.com}}<br />{{URL|https://www.covidlims.com/|COVIDLiMS.com}}
|linkedin          =  [https://www.linkedin.com/company/lablynx-inc-/ https://www.linkedin.com/company/lablynx-inc-/]
|footnotes        =
|intl              =  No
}}
}}
'''LabLynx, Inc.''' is a privately owned, funded, and managed American corporation that develops, supports, and markets [[laboratory information management system]] (LIMS) solutions. Its most well-known product is ELab, a browser-based LIMS offered as a local installation or under a scalable, hosted "[[software as a service]]" (SaaS) delivery model. The company’s primary clients include [[Laboratory|laboratories]] in the agriculture, clinical, environmental, [[Forensic science|forensics]], health care, and manufacturing industries, including government agencies. The company is known for introducing one of the first browser-based LIMS products in 1997<ref name="LS_prod">{{cite web |url=http://www.limsource.com/products/vatlanta.html |archiveurl=http://web.archive.org/web/20071012123126/http://www.limsource.com/products/vatlanta.html |archivedate=12 October 2007 |title=LIMSource: LIMS Vendor: LabLynx, Inc. |accessdate=22 October 2011}}</ref><ref name="LIMSwb" /> and being a long-term player in the [[laboratory informatics]] market.


==History==
==Sandbox begins below==
Before LabLynx was a company, it was a LIMS product offered by Atlanta Systems Consultants, Inc. (ASC).<ref name="LLX_archive1">{{cite web |url=http://www.lablynx.com/ |archiveurl=http://web.archive.org/web/19990125100717/http://www.lablynx.com/ |title=LABLynx On The Web |archivedate=25 January 1998 |accessdate=22 October 2011}}</ref><ref name="doh_fl">{{cite web |title=LABLynx on the Web |url=http://www.doh.state.fl.us/Irm/Apps/ihis/JADS/deh/Market%20Research/Background/asc_website.pdf |archiveurl=https://web.archive.org/web/20040831183340/http://www.doh.state.fl.us/Irm/Apps/ihis/JADS/deh/Market%20Research/background/asc_website.pdf |format=PDF |publisher=Florida Department of Health |date=8 March 2000 |accessdate=29 December 2015 |archivedate=31 August 2004}}</ref> Formed in 1992,<ref name="SoS_asc">{{cite web |url=https://ecorp.sos.ga.gov/BusinessSearch/BusinessInformation?businessId=863106 |title=Business Entity – Atlanta Systems Consultants, Inc. |publisher=Georgia Secretary of State |accessdate=29 December 2015}}</ref> ASC's LabLynx division later began work on a laboratory information management system designed specifically for a web browser. ASC demonstrated its new Internet Explorer-based LabLynx LIMS at [[Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy|Pittcon]] in 1997, among the first browser-based LIMS to appear at the time.<ref name="LS_prod" /><ref name="LIMSwb">{{cite book |title=LIMS Workbook - A Practical Guide |edition=3rd |author=McGinnis, Mike and Norman Perkins|chapter=I. Wireless LANs |year=2003 |pages=I-16 |publisher=Q2marketsite, Inc |asin=B00161Y71K}}</ref> The company again showcased LabLynx at Pittcon in 1998<ref name="LS_pitt98">{{cite web |url=http://www.limsource.com/calendar/pitt98.html |archiveurl=http://web.archive.org/web/19980529121944/http://www.limsource.com/calendar/pitt98.html |archivedate=29 May 1998 |title=LIMSource: Calendar: Pittcon ’98 Preview |accessdate=22 October 2011}}</ref> and soon after picked up a major LIMS-based contract with the U.S. Customs Service.<ref name="FBO">{{cite web |url=http://www.fbodaily.com/cbd/archive/1998/07(July)/30-Jul-1998/70awd003.htm |title=70 -- Laboratory Information Management Software (LIMS) (07/30/98) |publisher=FedBizOpps |accessdate=22 October 2011}}</ref>


<div class="col-sm-4 pull-right">
*Discussion and practical use of [[artificial intelligence]] (AI) in the [[laboratory]] is, perhaps to the surprise of some, not a recent phenomena. In the mid-1980s, researchers were developing computerized AI systems able "to develop automatic decision rules for follow-up analysis of &#91;[[clinical laboratory]]&#93; tests depending on prior information, thus avoiding the delays of traditional sequential testing and the costs of unnecessary parallel testing."<ref>{{Cite journal |last=Berger-Hershkowitz |first=H. |last2=Neuhauser |first2=D. |date=1987 |title=Artificial intelligence in the clinical laboratory |url=https://www.ccjm.org/content/54/3/165 |journal=Cleveland Clinic Journal of Medicine |volume=54 |issue=3 |pages=165–166 |doi=10.3949/ccjm.54.3.165 |issn=0891-1150 |pmid=3301059}}</ref> In fact, discussion of AI in general was ongoing even in the mid-1950s.<ref name="MinskyHeuristic56">{{cite book |url=https://books.google.com/books?hl=en&lr=&id=fvWNo6_IZGUC&oi=fnd&pg=PA1 |title=Heuristic Aspects of the Artificial Intelligence Problem |author=Minsky, M. |publisher=Ed Services Technical Information Agency |date=17 December 1956 |accessdate=16 February 2023}}</ref><ref>{{Cite journal |last=Minsky |first=Marvin |date=1961-01 |title=Steps toward Artificial Intelligence |url=http://ieeexplore.ieee.org/document/4066245/ |journal=Proceedings of the IRE |volume=49 |issue=1 |pages=8–30 |doi=10.1109/JRPROC.1961.287775 |issn=0096-8390}}</ref>
<div class="thumbnail img-thumbnail">[[File:2400_Lake_Park_Drive%2C_Smyrna%2C_Georgia.jpg|right|350px|LabLynx home office]]</div>
</div>


By July 2000, the LabLynx division of ASC separated to become its own incorporated entity.<ref name="SoS_llx" /> And while ASC eventually ceased to exist in 2005,<ref name="SoS_asc" /> LabLynx, Inc. went on to diversify its offerings. LabLynx’s browser-based LIMS previously demonstrated at Pittcon in 1997 expanded to become ELab, which in 2001 took on an application service provider (ASP) model of distribution.<ref name="LS_prod2">{{cite web |url=http://www.limsource.com/products/vatlanta.html |archiveurl= http://web.archive.org/web/20010409200118/http://www.limsource.com/products/vatlanta.html |archivedate=9 April 2001 |title=LIMSource: LIMS Vendor: Atlanta Systems Consultants, Inc. |accessdate=22 October 2011}}</ref> In 2004 LabLynx released a browser-based tool called openLIMS, which gave consultants and end-users the ability "to build custom LIMS solutions that are geared to the exact operational needs of many different laboratories."<ref>{{cite web |url=http://www.laboratorytalk.com/news/lbl/lbl100.html |archiveurl=https://web.archive.org/web/20120419143618/http://www.laboratorytalk.com/news/lbl/lbl100.html |title=Build your own LIMS: News from LabLynx |work=LaboratoryTalk.com |publisher=Pro-Talk Ltd |date=6 January 2004 |accessdate=29 December 2015 |archivedate=19 April 2012}}</ref>
*Hiring demand for laboratorians with AI experience (2015–18) has historically been higher in non-healthcare industries, such as manufacturing, mining, and agriculture, shedding a light on how AI adoption in the clinical setting may be lacking. According to the Brookings Institute, "Even for the relatively-skilled job postings in hospitals, which includes doctors, nurses, medical technicians, research lab workers, and managers, only approximately 1 in 1,250 job postings required AI skills." They add: "AI adoption may be slow because it is not yet useful, or because it may not end up being as useful as we hope. While our view is that AI has great potential in health care, it is still an open question."<ref name=":11">{{Cite web |last=Goldfarb, A.; Teodoridis, F. |date=09 March 2022 |title=Why is AI adoption in health care lagging? |work=Series: The Economics and Regulation of Artificial Intelligence and Emerging Technologies |url=https://www.brookings.edu/research/why-is-ai-adoption-in-health-care-lagging/ |publisher=Brookings Institute |accessdate=17 February 2023}}</ref>


On June 19, 2006, LabLynx established the Laboratory Informatics Institute, an open membership group with the purpose of advancing the field of laboratory informatics and shaping the standards associated with it.<ref name="LII">{{cite web |title=Laboratory Informatics Institute Established |url=http://www.limsfinder.com/BlogDetail.aspx?id=31049_0_3_0_C |archiveurl=https://web.archive.org/web/20161027121044/http://www.limsfinder.com/BlogDetail.aspx?id=31049_0_3_0_C |publisher=Laboratory Informatics Institute, Inc. |date=17 July 2006 |archivedate=27 October 2016 |accessdate=26 January 2018}}</ref> LabLynx made further moves to better its LIMS offerings in August 2008, renewing and expanding its contract with Nagarro, Inc., a U.S.-based technology consulting firm. The collaboration allowed LabLynx to upgrade its existing LIMS software to .NET architecture and expand its initiative to create and market a SaaS-based LIMS.<ref name="Nagarro1">{{cite web |url=http://www.nagarro.com/NewsEvents/Press%20Releases/LABLynx%20Extends%20Contract%20with.aspx |archiveurl=https://web.archive.org/web/20120716033503/http://nagarro.com/NewsEvents/Press%20Releases/LABLynx%20Extends%20Contract%20with.aspx |title=LABLynx Extends Contract with Nagarro to Include Additional Product Development and SaaS Projects |publisher=Nagarro, Inc |date=20 August 2008 |accessdate=29 December 2015 |archivedate=16 July 2012}}</ref> Less than a year after the announced renewed partnership, LabLynx revealed its redeveloped webLIMS product to the public, featuring ELab in a SaaS model and additional integration of developer tools to allow users to create and modify modules for the LIMS.<ref name="webLIMS1">{{cite web |title=LabLynx launches the new webLiMS.com, Laboratory SaaS Provider |url=http://scienceandresearch.argylenews.com/press_release.aspx?LabLynx-launches-the-new-webLiMScom-Laboratory-SaaS-Provider-542 |archiveurl=https://web.archive.org/web/20160304101223/http://scienceandresearch.argylenews.com/press_release.aspx?LabLynx-launches-the-new-webLiMScom-Laboratory-SaaS-Provider-542 |publisher=Argyle News |date=6 March 2009 |archivedate=04 March 2016 |accessdate=26 January 2018}}</ref><ref name="webLIMS2">{{cite web |title=Weblims – LabLynx |url=https://www.scientific-computing.com/press-releases/weblims |publisher=Scientific Computing World |date=6 March 2009 |accessdate=26 January 2018}}</ref> This move to a cloud-based SaaS model brought renewed interest in the company’s LIMS, with clients like the Georgia Department of Agriculture<ref name="ChemEng1">{{cite web |url=https://cen.acs.org/articles/88/i21/LIMS-Cloud.html |title=LIMS In The Cloud |author=Mullin, Rick |work=Chemical & Engineering News |publisher=American Chemical Society |date=24 May 2010 |accessdate=24 September 2021}}</ref> and Cypress Bioscience<ref>{{cite web |url=https://www.pharmaceuticalonline.com/doc/saas-model-turns-lims-paradigm-on-its-0001 |title=SaaS Model Turns LIMS Paradigm On Its Head |author=Dubin, Cindy |publisher=VertMarkets, Inc |work=Pharmaceutical Online |date=29 July 2010 |accessdate=24 September 2021}}</ref><ref>{{cite web |title=SaaS - Is a web hosted LIMS right for your laboratory? |url=http://www.lablynx.com/ArticlesBlogs/tabid/326/articleType/ArticleView/articleId/13/SaaS--Is-a-web-hosted-LIMS-right-for-your-laboratory.aspx |archiveurl=https://web.archive.org/web/20120509064611/http://www.lablynx.com/ArticlesBlogs/tabid/326/articleType/ArticleView/articleId/13/SaaS--Is-a-web-hosted-LIMS-right-for-your-laboratory.aspx |publisher=LabLynx, Inc |date=15 August 2009 |accessdate=29 December 2015 |archivedate=09 May 2012}}</ref> taking on the new LIMS.
*Today, AI is being practically used in not only clinical diagnostic laboratories but also clinical research labs, life science labs, and research and development (R&D) labs, and more. Practical uses of AI can be found in:


In 2011, LabLynx was involved in an initiative to standardize and structure the transmission of laboratory data that first originates in a LIMS or LIS and then moves to a person's or population of people's [[electronic health record]]s.<ref>{{cite book |title=Laboratory Results Interface (LRI) Pilots Guide |edition= v0.9.4.093011 |author=Clarke, Ann | year=2011 |pages=1–2 |publisher=LabLynx/mdDigest |url=http://wiki.siframework.org/file/view/LRI_Pilots_Guide_Draft_v0_9_4_093011.docx |archiveurl=https://web.archive.org/web/20140812142427/http://wiki.siframework.org/file/view/LRI_Pilots_Guide_Draft_v0_9_4_093011.docx |archivedate=12 August 2014}}</ref> This laboratory results interface (LRI) pilot began in August 2011 and included collaborations with the supported open source project mdDigest and the U.S. Office of the National Coordinator for Health Information Technology (ONC).<ref>{{cite web |title=PROJECT BRIEF: LabLynx/mdDigest Pilot |url=http://wiki.siframework.org/LabLynx+Pilot+Brief |archiveurl=https://web.archive.org/web/20140812142106/http://wiki.siframework.org/LabLynx+Pilot+Brief |publisher= LabLynx/mdDigest |archivedate=12 August 2016 |accessdate=16 January 2018}}</ref>
:clinical research labs<ref name=":0">{{Cite journal |last=Damiani |first=A. |last2=Masciocchi |first2=C. |last3=Lenkowicz |first3=J. |last4=Capocchiano |first4=N. D. |last5=Boldrini |first5=L. |last6=Tagliaferri |first6=L. |last7=Cesario |first7=A. |last8=Sergi |first8=P. |last9=Marchetti |first9=A. |last10=Luraschi |first10=A. |last11=Patarnello |first11=S. |date=2021-12-07 |title=Building an Artificial Intelligence Laboratory Based on Real World Data: The Experience of Gemelli Generator |url=https://www.frontiersin.org/articles/10.3389/fcomp.2021.768266/full |journal=Frontiers in Computer Science |volume=3 |pages=768266 |doi=10.3389/fcomp.2021.768266 |issn=2624-9898}}</ref>
:hospitals<ref name=":0" /><ref name=":1">{{Cite journal |last=University of California, San Francisco |last2=Adler-Milstein |first2=Julia |last3=Aggarwal |first3=Nakul |last4=University of Wisconsin-Madison |last5=Ahmed |first5=Mahnoor |last6=National Academy of Medicine |last7=Castner |first7=Jessica |last8=Castner Incorporated |last9=Evans |first9=Barbara J. |last10=University of Florida |last11=Gonzalez |first11=Andrew A. |date=2022-09-29 |title=Meeting the Moment: Addressing Barriers and Facilitating Clinical Adoption of Artificial Intelligence in Medical Diagnosis |url=https://nam.edu/meeting-the-moment-addressing-barriers-and-facilitating-clinical-adoption-of-artificial-intelligence-in-medical-diagnosis |journal=NAM Perspectives |volume=22 |issue=9 |doi=10.31478/202209c |pmc=PMC9875857 |pmid=36713769}}</ref>
:medical diagnostics labs<ref name=":1" /><ref name=":12">{{Cite web |last=Government Accountability Office (GAO); National Academy of Medicine (NAM) |date=September 2022 |title=Artificial Intelligence in Health Care: Benefits and Challenges of Machine Learning Technologies for Medical Diagnostics |url=https://www.gao.gov/assets/gao-22-104629.pdf |format=PDF |publisher=Government Accountability Office |accessdate=16 February 2023}}</ref><ref name=":13">{{Cite journal |last=Wen |first=Xiaoxia |last2=Leng |first2=Ping |last3=Wang |first3=Jiasi |last4=Yang |first4=Guishu |last5=Zu |first5=Ruiling |last6=Jia |first6=Xiaojiong |last7=Zhang |first7=Kaijiong |last8=Mengesha |first8=Birga Anteneh |last9=Huang |first9=Jian |last10=Wang |first10=Dongsheng |last11=Luo |first11=Huaichao |date=2022-09-24 |title=Clinlabomics: leveraging clinical laboratory data by data mining strategies |url=https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-022-04926-1 |journal=BMC Bioinformatics |language=en |volume=23 |issue=1 |pages=387 |doi=10.1186/s12859-022-04926-1 |issn=1471-2105 |pmc=PMC9509545 |pmid=36153474}}</ref><ref name=":7">{{Cite journal |last=DeYoung |first=B. |last2=Morales |first2=M. |last3=Giglio |first3=S. |date=2022-08-04 |title=Microbiology 2.0–A “behind the scenes” consideration for artificial intelligence applications for interpretive culture plate reading in routine diagnostic laboratories |url=https://www.frontiersin.org/articles/10.3389/fmicb.2022.976068/full |journal=Frontiers in Microbiology |volume=13 |pages=976068 |doi=10.3389/fmicb.2022.976068 |issn=1664-302X |pmc=PMC9386241 |pmid=35992715}}</ref><ref name=":5">{{Cite web |last=Schut, M. |date=01 December 2022 |title=Get better with bytes |url=https://www.amsterdamumc.org/en/research/news/get-better-with-bytes.htm |publisher=Amsterdam UMC |accessdate=16 February 2023}}</ref><ref name="AlbanoCal19">{{cite web |url=https://physicianslab.com/calculations-to-diagnosis-the-artificial-intelligence-shift-thats-already-happening/ |title=Calculations to Diagnosis: The Artificial Intelligence Shift That’s Already Happening |author=Albano, V.; Morris, C.; Kent, T. |work=Physicians Lab |date=06 December 2019 |accessdate=16 February 2023}}</ref>
:chromatography labs<ref name="AlbanoCal19" />
:biology and life science labs<ref name=":6">{{Cite journal |last=de Ridder |first=Dick |date=2019-01 |title=Artificial intelligence in the lab: ask not what your computer can do for you |url=https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.13317 |journal=Microbial Biotechnology |language=en |volume=12 |issue=1 |pages=38–40 |doi=10.1111/1751-7915.13317 |pmc=PMC6302702 |pmid=30246499}}</ref>
:medical imaging centers<ref name="Brandao-de-ResendeAIWeb22">{{cite web |url=https://siim.org/page/22w_clinical_adoption_of_ai |title=AI Webinar: Clinical Adoption of AI Across Image Producing Specialties |author=Brandao-de-Resende, C.; Bui, M.; Daneshjou, R. et al. |publisher=Society for Imaging Informatics in Medicine |date=11 October 2022}}</ref>
:ophthalmology clinics<ref>{{Cite journal |last=He |first=Mingguang |last2=Li |first2=Zhixi |last3=Liu |first3=Chi |last4=Shi |first4=Danli |last5=Tan |first5=Zachary |date=2020-07 |title=Deployment of Artificial Intelligence in Real-World Practice: Opportunity and Challenge |url=https://journals.lww.com/10.1097/APO.0000000000000301 |journal=Asia-Pacific Journal of Ophthalmology |language=en |volume=9 |issue=4 |pages=299–307 |doi=10.1097/APO.0000000000000301 |issn=2162-0989}}</ref>
:reproduction clinics<ref name=":9">{{Cite journal |last=Trolice |first=Mark P. |last2=Curchoe |first2=Carol |last3=Quaas |first3=Alexander M |date=2021-07 |title=Artificial intelligence—the future is now |url=https://link.springer.com/10.1007/s10815-021-02272-4 |journal=Journal of Assisted Reproduction and Genetics |language=en |volume=38 |issue=7 |pages=1607–1612 |doi=10.1007/s10815-021-02272-4 |issn=1058-0468 |pmc=PMC8260235 |pmid=34231110}}</ref><ref name="ESHREArti22">{{cite web |url=https://www.focusonreproduction.eu/article/ESHRE-News-22AI |title=Annual Meeting 2022: Artificial intelligence in embryology and ART |author=European Society of Human Reproduction and Embryology |work=Focus on Reproduction |date=06 July 2022 |accessdate=16 February 2023}}</ref><ref name="HinckleyApply21">{{cite web |url=https://rscbayarea.com/blog/applying-ai-for-better-ivf-success |title=Applying AI (Artificial Intelligence) in the Lab for Better IVF Success |author=Hinckley, M. |work=Reproductive Science Center Blog |publisher=Reproductive Science Center of the Bay Area |date=17 March 2021 |accessdate=16 February 2023}}</ref>
:digital pathology labs<ref name="YousifArt21">{{cite web |url=https://clinlabint.com/artificial-intelligence-is-the-key-driver-for-digital-pathology-adoption/ |title=Artificial intelligence is the key driver for digital pathology adoption |author=Yousif, M.; McClintock, D.S.; Yao, K. |work=Clinical Laboratory Int |publisher=PanGlobal Media |date=2021 |accessdate=16 February 2023}}</ref>
:material testing labs<ref name=":2">{{Cite journal |last=MacLeod |first=B. P. |last2=Parlane |first2=F. G. L. |last3=Morrissey |first3=T. D. |last4=Häse |first4=F. |last5=Roch |first5=L. M. |last6=Dettelbach |first6=K. E. |last7=Moreira |first7=R. |last8=Yunker |first8=L. P. E. |last9=Rooney |first9=M. B. |last10=Deeth |first10=J. R. |last11=Lai |first11=V. |date=2020-05-15 |title=Self-driving laboratory for accelerated discovery of thin-film materials |url=https://www.science.org/doi/10.1126/sciadv.aaz8867 |journal=Science Advances |language=en |volume=6 |issue=20 |pages=eaaz8867 |doi=10.1126/sciadv.aaz8867 |issn=2375-2548 |pmc=PMC7220369 |pmid=32426501}}</ref><ref name=":3">{{Cite journal |last=Chibani |first=Siwar |last2=Coudert |first2=François-Xavier |date=2020-08-01 |title=Machine learning approaches for the prediction of materials properties |url=http://aip.scitation.org/doi/10.1063/5.0018384 |journal=APL Materials |language=en |volume=8 |issue=8 |pages=080701 |doi=10.1063/5.0018384 |issn=2166-532X}}</ref><ref name="MullinTheLab21">{{Cite journal |last=Mullin, R. |date=28 March 2021 |title=The lab of the future is now |url=http://cen.acs.org/business/informatics/lab-future-ai-automated-synthesis/99/i11 |journal=Chemical & Engineering News |volume=99 |issue=11 |archiveurl=https://web.archive.org/web/20220506192926/http://cen.acs.org/business/informatics/lab-future-ai-automated-synthesis/99/i11 |archivedate=06 May 2022 |accessdate=16 February 2023}}</ref>
:chemical experimentation and molecular discovery labs<ref name="MullinTheLab21" /><ref name=":4">{{Cite journal |last=Burger |first=Benjamin |last2=Maffettone |first2=Phillip M. |last3=Gusev |first3=Vladimir V. |last4=Aitchison |first4=Catherine M. |last5=Bai |first5=Yang |last6=Wang |first6=Xiaoyan |last7=Li |first7=Xiaobo |last8=Alston |first8=Ben M. |last9=Li |first9=Buyi |last10=Clowes |first10=Rob |last11=Rankin |first11=Nicola |date=2020-07-09 |title=A mobile robotic chemist |url=https://www.nature.com/articles/s41586-020-2442-2.epdf?sharing_token=HOkIS6P5VIAo2_l3nRELmdRgN0jAjWel9jnR3ZoTv0Nw4yZPDO1jBpP52iNWHbb8TakOkK906_UHcWPTvNxCmzSMpAYlNAZfh29cFr7WwODI2U6eWv38Yq2K8odHCi-qwHcEDP18OjAmH-0KgsVgL5CpoEaQTCvbmhXDSyoGs6tIMe1nuABTeP58z6Ck3uULcdCtVQ66X244FsI7uH8GnA%3D%3D&tracking_referrer=cen.acs.org |journal=Nature |language=en |volume=583 |issue=7815 |pages=237–241 |doi=10.1038/s41586-020-2442-2 |issn=0028-0836}}</ref><ref name="LemonickExplore20">{{Cite journal |last=Lemonick, S. |date=06 April 2020 |title=Exploring chemical space: Can AI take us where no human has gone before? |url=https://cen.acs.org/physical-chemistry/computational-chemistry/Exploring-chemical-space-AI-take/98/i13 |journal=Chemical & Engineering News |volume=98 |issue=13 |archiveurl=https://web.archive.org/web/20200729004137/https://cen.acs.org/physical-chemistry/computational-chemistry/Exploring-chemical-space-AI-take/98/i13 |archivedate=29 July 2020 |accessdate=16 February 2023}}</ref>
:quantum physics labs<ref name="DoctrowArti19">{{cite web |url=https://www.pnas.org/post/podcast/artificial-intelligence-laboratory |title=Artificial intelligence in the laboratory |author=Doctrow, B. |work=PNAS Science Sessions |date=16 December 2019 |accessdate=16 February 2023}}</ref>


In February 2015, LabLynx announced the introduction of HealthCloudPOL, a cloud-based [[laboratory information system]] (LIS) for the physician office laboratory (POL), making the basic starter package free to users.<ref name="HCPOL_LinkedIn">{{cite web |url=https://www.linkedin.com/company/lablynx-inc./comments?topic=5979788253375520768&type=U&scope=209217&stype=C&a=NHFX |title=Security, Reliability, and Regulatory Compliance: healthcloudpol.com |author=LabLynx, Inc |publisher=LinkedIn Corporation |date=February 2015 |accessdate=29 December 2015}}</ref><ref name="HCPOLArch">{{cite web |url=http://www.healthcloudpol.com/ |archiveurl=https://web.archive.org/web/20150314182554/www.healthcloudpol.com |title=HealthCloudPOL — the FREE Cloud-based Physician Office LIS |publisher=LabLynx, Inc |archivedate=14 March 2015 |accessdate=26 January 2018}}</ref> That product line soon after changed names, becoming sciCloud.net.
*What's going on in these labs?


In the summer of 2019, LabLynx released its CannaQA LIMS software for the cannabis testing industry.<ref name="LLPWelcome19">{{cite web |url=https://www.lablynxpress.com/index.php?title=Welcome_to_CannaQA&action=history |archiveurl=https://web.archive.org/web/20220411152725/https://www.lablynxpress.com/index.php?title=Welcome_to_CannaQA&action=history |title=Welcome to CannaQA - History |work=LabLynx Press |publisher=LabLynx, Inc |date=11 July 2019 |archivedate=11 April 2022 |accessdate=11 April 2022}}</ref> The solution's name changed to "ELab LIMS for Cannabis" in April 2022.
:'''Materials science''': The creation of "a modular robotic platform driven by a model-based optimization algorithm capable of autonomously optimizing the optical and electronic properties of thin-film materials by modifying the film composition and processing conditions ..."<ref name=":2" />
:'''Materials science''': "Most of the applications of [machine learning (ML)] in chemical and materials sciences, as we have said, feature supervised learning algorithms. The goal there is to supplement or replace traditional modeling methods, at the quantum chemical or classical level, in order to predict the properties of molecules or materials directly from their structure or their chemical composition ... Our research group was applying the same idea on a narrower range of materials, trying to confirm that for a given chemical composition, geometrical descriptors of a material’s structure could lead to accurate predictions of its mechanical features."<ref name=":3" />
:'''Life science''': "In biological experiments, we generally cannot as easily declare victory, but we can use the systems biology approach of cycling between experimentation and modelling to see which sequences, when tested, are most likely to improve the model. In artificial intelligence, this is called active learning, and it has some similarity to the way in which we as humans learn as infants: we get some help from parents and teachers, but mainly model the world around us by exploring it and interacting with it. Ideally then, we would recreate such an environment for our machine learning algorithms in the laboratory, where we start with an initial ‘infant’ model of a certain regulatory system or protein function and let the computer decide what sequence designs to try out – a deep learning version of the ‘robot scientist’. Microbes are ideal organisms for such an approach, given the ease and speed with which they can be grown and genetically manipulated. Combined with laboratory automation, many microbial experiments can (soon) be performed with minimal human intervention, ranging from strain construction and screening, such as operated by Amyris, Gingko, Transcriptic, etc., to full-genome engineering or even the design of microbial ecologies."<ref name=":6" />
:'''Digital pathology''': "The collaboration combines two AI solutions, VistaPath’s Sentinel, the world’s first automated tissue grossing platform, and Gestalt’s AI Requisition Engine (AIRE), a leading-edge AI algorithm for accessioning, to raise the bar in AI-driven pathology digitization. Designed to make tissue grossing faster and more accurate, VistaPath’s Sentinel uses a high-quality video system to assess specimens and create a gross report 93% faster than human technicians with 43% more accuracy. It not only improves on quality by continuously monitoring the cassette, container, and tissue to reduce mislabeling and specimen mix-up, but also increases traceability by retaining original images for downstream review."<ref>{{Cite web |last=VistaPath |date=28 July 2022 |title=VistaPath Launches New Collaboration with Gestalt Diagnostics to Further Accelerate Pathology Digitization |work=PR Newswire |url=https://www.prnewswire.com/news-releases/vistapath-launches-new-collaboration-with-gestalt-diagnostics-to-further-accelerate-pathology-digitization-301594718.html |publisher=Cision US Inc |accessdate=17 February 2023}}</ref>
:'''Chemistry and molecular science''': "The benefits of combining automated experimentation with a layer of artificial intelligence (AI) have been demonstrated for flow reactors, photovoltaic films, organic synthesis, perovskites and in formulation problems. However, so far no approaches have integrated mobile robotics with AI for chemical experiments. Here, we built Bayesian optimization into a mobile robotic workflow to conduct photocatalysis experiments within a ten-dimensional space."<ref name=":4" />
:'''Chemistry and immunology''': "Chemistry and immunology laboratories are particularly well-suited to leverage machine learning because they generate large, highly structured data sets, Schulz and others wrote in a separate review paper. Labor-intensive processes used for interpretation and quality control of electrophoresis traces and mass spectra could benefit from automation as the technology improves, they said. Clinical chemistry laboratories also generate digital images—such as urine sediment analysis—that may be highly conducive to semiautomated analyses, given advances in computer vision, the paper noted."<ref name=":8">{{Cite web |last=Blum, K. |date=01 January 2023 |title=A Status Report on AI in Laboratory Medicine |work=Clinical Laboratory News |url=https://www.aacc.org/cln/articles/2023/janfeb/a-status-report-on-ai-in-laboratory-medicine |publisher=American Association for Clinical Chemistry |accessdate=17 February 2023}}</ref>
:'''Clinical research''': "... retrospective analysis of existing patient data for descriptive and clustering purposes [and] automation of knowledge extraction, ranging from text mining, patient selection for trials, to generation of new research hypotheses ..."<ref name=":0" />
:'''Clinical research''': "AI ... offers a further layer to the laboratory system by analyzing all experimental data collected by experiment devices, whether it be a sensor or a collaborative robot. From data collected, AI is able to produce hypotheses and predict which combination of materials or temperature is desired for the experiment. In short, this system will allow scientists to be aided by a highly intelligent system which is constantly monitoring and analyzing the experimental output. In this way, AI will help an experiment from its inception to conclusion."<ref>{{Cite web |last=Chubb, P. |date=03 November 2020 |title=How disruptive technology is helping laboratories combat COVID-19 |url=https://datafloq.com/read/disruptive-technologies-lab-help-us-prepare-future-pandemics/ |publisher=Datafloq |accessdate=16 February 2023}}</ref>
:'''Clinical research/medical diagnostics''': "Artificial intelligence (AI) in the laboratory is primarily used to make sense of big data, the almost impossibly large sets of data that biologists and pharmaceutical R&D teams are accustomed to working with. AI algorithms can parse large amounts of data in a short amount of time and turn that data into visualizations that viewers can easily understand. In certain data-intensive fields, such as genomic testing and virus research, AI algorithms are the best way to sort through the data and do some of the pattern recognition work."<ref>{{Cite web |last=Stewart, B. |date=18 March 2021 |title=Using LIMS for Data Visualization |work=CSols Insights |url=https://www.csolsinc.com/insights/published-articles/using-lims-for-data-visualization/ |publisher=CSols, Inc |accessdate=17 February 2023}}</ref>
:'''Medical diagnostics''': Development and implementation of [[Clinical decision support system|clinical decision support systems]] <ref name=":0" /><ref name=":1" />
:'''Medical diagnostics''': "Finally, in the laboratory, AI reduces the number of unnecessary blood samples when diagnosing infection. Instead of the 'gold standard blood sample' that takes 24-72 hours, the algorithm can predict the outcome of the blood sample with almost 80% accuracy based on demographics, vital signs, medications, and laboratory and radiology results. These are all examples of how Artificial Intelligence can be used to test better and faster with information that already exists. This saves time and costs."<ref name=":5" />
:'''Medical diagnostics''': "Chang sees two overarching classes of AI models: those that tackle internal challenges in the lab, such as how to deliver more accurate results to clinicians; and those that seek to identify cohorts of patients and care processes to close quality gaps in health delivery systems. The lab, however, 'isn’t truly an island,' said Michelle Stoffel, MD, PhD, associate chief medical information officer for laboratory medicine and pathology at M Health Fairview and the University of Minnesota in Minneapolis. 'When other healthcare professionals are working with electronic health records or other applications, there could be AI-driven tools, or algorithms used by an institution’s systems that may draw on laboratory data.'"<ref name=":8" />
:'''Medical diagnostics''': AI is used for the formulation of reference ranges, improvement of quality control, and automated interpretation of results. "Continuous monitoring of specimen acceptability, collection and transport can result in the prompt identification and correction of problems, leading to improved patient care and a reduction in unnecessary redraws and delays in reporting results."<ref name=":13" />
:'''Reproduction science''': "The field of AI is the marriage of humans and computers while reproductive medicine combines clinical medicine and the scientific laboratory of embryology. The application of AI has the potential to disconnect healthcare professionals from patients through algorithms, automated communication, and clinical imaging. However, in the embryology laboratory, AI, with its focus on gametes and embryos, can avoid the same risk of distancing from the patient. Areas of application of AI in the laboratory would be to enhance and automate embryo ranking through analysis of images, the ultimate goal being to predict successful implantation. Might such a trend obviate the need for embryo morphological assessment, time-lapse imaging and preimplantation genetic testing for aneuploidy (PGT-A), including mosaicism. Additionally, AI could assist with automation through analysis of testicular sperm samples searching for viable gametes, embryo grading uniformity."<ref name=":9" />
:'''Chromatography-heavy sciences''': " A great example of this is AI in the Liquid Chromatography Mass Spectrometry (LC-MS) field. LC-MS is a great tool used to measure various compounds in the human body, including everything from hormone levels to trace metals. One of the ways AI has already integrated with LC-MS is how it cuts down on the rate limiting steps of LC-MS, which more often than not are sample prep and LC separations. One system that Physicians Lab has made use of is parallel processing using SCIEX MPX 2.0 High Throughput System. This system can couple parallel runs with one LCMS instrument, resulting in twice the speed with no loss to accuracy. It can do this by staggering two runs either using the same method, or different methods entirely. What really makes this system great is its ability to automatically detect carryover and inject solvent blanks to clean the instrument. The system will then continue its analyzing, while automatically reinjecting samples that may be affected by the carryover. It will also flag high concentration without user input, allowing for easy detection of possibly faulty samples. This allows it to operate without users from startup to shut down. Some of the other ways that it can be used to increase efficiency are by using integrated network features to work on anything from streamlining management to increased throughput."<ref name="AlbanoCal19" />
:'''Most any lab''': "Predictive analytics, for example, is one tool that the Pistoia Alliance is using to better understand laboratory instruments and how they might fail over time... With the right data management strategies and careful consideration of metadata, how to best store data so that it can be used in future AI and ML workflows is essential to the pursuit of AI in the laboratory. Utilizing technologies such as LIMS and ELN enables lab users to catalogue data, providing context and instrument parameters that can then be fed into AI or ML systems. Without the correct data or with mismatched data types, AI and ML will not be possible, or at the very least, could provide undue bias trying to compare data from disparate sources."<ref>{{Cite web |date=29 January 2021 |title=Data Analytics |work=Scientific Computing World - Building a Smart Laboratory 2020 |url=https://www.scientific-computing.com/feature/data-analytics-0 |publisher=Europa Science Ltd |accessdate=17 February 2023}}</ref>
:'''Most any lab''': "When the actionable items are automatically created by Optima, the 'engine' starts working. An extremely sophisticated algorithm is able to assign the tasks to the resources, both laboratory personnel and instruments, according to the system configuration. Optima, thanks to a large amount of time dedicated to research the best way to automate this critical process, is able to automate most of the lab resource scheduling."<ref>{{Cite web |last=Optima Team |date=15 December 2020 |title=The concept of machine learning applied to lab resources scheduling |work=Optima Blog |url=https://www.optima.life/blog/the-concept-of-machine-learning-applied-to-lab-resources-scheduling/ |publisher=Optima PLC Tracking Tools S.L |accessdate=17 February 2023}}</ref>


In April 2020, LabLynx announced it had modified its existing LIMS platform to effectively manage [[COVID-19]] workflows, and that its implementation could be deployed in two to five days.<ref name="PRNLabLynx20">{{cite web |url=https://www.prnewswire.com/news-releases/lablynx-joins-the-covid-19-fight-by-introducing-new-covidlims-301037802.html |title=LabLynx Joins the COVID-19 Fight by Introducing New CovidLiMS |work=PR Newswire |author=LabLynx, Inc |date=09 April 2020 |accessdate=20 October 2020}}</ref>
*A number of challenges exist in the realm of effectively and securely implementing AI in the laboratory. This includes:


===Community history===
:Ethical and privacy challenges<ref name=":0" /><ref name=":8" /><ref name=":10" />
Since transitioning from Atlanta Systems Consultants, Inc. to LabLynx, Inc. in 2000, LabLynx has become increasingly active in the laboratory informatics community. Projects that LabLynx has started or been involved in within the community over the years include:
:Algorithmic limitations<ref name=":11" />
:Data access limitations, including "where to get it, how to share it, and how to know when you have enough to train a machine-learning system that will produce good results"<ref name=":11" /><ref name=":8" /><ref name=":14">{{Cite web |last=Sherwood, L. |date=10 February 2022 |title=SLAS 2022: Barriers remain to AI adoption in life sciences |work=LabPulse.com Showcasts |url=https://www.labpulse.com/showcasts/slas/2022/article/15300130/slas-2022-barriers-remain-to-ai-adoption-in-life-sciences |publisher=Science and Medicine Group |accessdate=17 February 2023}}</ref><ref name=":15">{{Cite journal |last=Bellini |first=Claudia |last2=Padoan |first2=Andrea |last3=Carobene |first3=Anna |last4=Guerranti |first4=Roberto |date=2022-11-25 |title=A survey on Artificial Intelligence and Big Data utilisation in Italian clinical laboratories |url=https://www.degruyter.com/document/doi/10.1515/cclm-2022-0680/html |journal=Clinical Chemistry and Laboratory Medicine (CCLM) |language=en |volume=60 |issue=12 |pages=2017–2026 |doi=10.1515/cclm-2022-0680 |issn=1434-6621}}</ref>
:Data integration and transformation issues<ref name=":0" /><ref name=":15" />
:Regulatory barriers<ref name=":11" /><ref name=":12" />
:Misaligned incentives<ref name=":11" />
:Lack of knowledgeable/skilled talent<ref name=":0" /><ref name=":8" /><ref name=":14" /><ref name=":15" />
:Cost of skilled talent and infrastructure for maintaining and updating AI systems<ref name=":8" />
:Legacy systems running outdated technologies<ref name=":14" />
:Lack of IT systems or specialized software systems<ref name=":15" />
:Lack of standardized, best practices-based methods of validating algorithms<ref name=":8" />
:Failure to demonstrate real-world performance<ref name=":12" />
:Failure to meet the needs of the professionals using it<ref name=":12" />


* the Laboratory Informatics Institute, an open trade association with the mission of educating, standardizing, and promoting the laboratory informatics industry<ref name="LII" />
*Given those challenges, some considerations should be made about implementing AI-based components in the laboratory. Examples include:
* LIMSfinder, an online interactive magazine released by the Laboratory Informatics Institute that aims to be "the best resource for information technology in the laboratory"<ref>{{cite web|title=LIMSfinder Home |url=http://www.limsfinder.com/Home.aspx |archiveurl=https://web.archive.org/web/20170306214114/http://www.limsfinder.com/Home.aspx |publisher=Laboratory Informatics Institute, Inc. |archivedate=06 March 2017 |accessdate=26 January 2018}}</ref>
* LIMSbook, a LIMS buyer’s guide released by the Laboratory Informatics Institute<ref>{{cite web|title=The LIMS Book |url=http://limsbook.com/ |archiveurl=https://web.archive.org/web/20140104091826/http://limsbook.com/ |publisher=Laboratory Informatics Institute, Inc. |archivedate=04 January 2014 |accessdate=26 January 2018}}</ref>
* LIMSforum, a LinkedIn discussion group created to facilitate the exchange of ideas and technical information across the fields of laboratory, science, and [[health informatics]]<ref>{{cite web |url=http://www.laboratorytalk.com/news/lbl/lbl103.html |archiveurl=https://web.archive.org/web/20120419143627/http://www.laboratorytalk.com/news/lbl/lbl103.html |title=Lablynx - latest company news |work=LaboratoryTalk.com |publisher=Pro-Talk Ltd |date=25 August 2009 |accessdate=29 December 2015 |archivedate=19 April 2012}}</ref><ref>{{cite web |title=LiMS forum - Laboratory Informatics Institute user's group for LIMS, Scientific & Health Informatics |url=http://www.linkedin.com/groups?about=&gid=2069898 |publisher=LinkedIn.com |accessdate=22 October 2011}}</ref>; this later became a stand-alone community web portal.<ref name="LIMSForumSite">{{cite web |url=https://www.limsforum.com/ |title=LiMSForum |publisher=LabLynx, Inc |accessdate=26 January 2018}}</ref>
* LIMSuniversity, an open-access learning resource released by the Laboratory Informatics Institute, targeted towards laboratories and the LIMS community<ref>{{cite web |title=LiMSuniversity.com, the on-line, Open Access, Virtual Learning Center for Laboratory Informatics users and professionals |url=http://www.limsfinder.com/BlogDetail.aspx?id=35134_0_25_0_C |archiveurl=https://web.archive.org/web/20170306214123/http://www.limsfinder.com/BlogDetail.aspx?id=35134_0_25_0_C |publisher=Laboratory Informatics Institute, Inc. |date=4 April 2011 |archivedate=06 March 2017 |accessdate=26 January 2018}}</ref>
* LIMSwiki, a Creative Commons-licensed wiki with the goal of bringing related informatics communities together to maintain a repository of information about the industry<ref>{{cite web |title=LIMSwiki mission |url=https://www.limswiki.org/index.php/LIMSwiki_mission |date=4 June 2015 |accessdate=26 January 2018}}</ref>
* CannaQAwiki, a  Creative Commons-licensed wiki with the goal of providing content as it relates to analytically testing the ''Cannabis'' plant and its constituents in the laboratory, as well as the regulatory aspects that surround it<ref>{{cite web |title=Welcome to CannaQAwiki |url=https://www.cannaqa.wiki/index.php?title=Main_Page |date=03 September 2021 |accessdate=24 September 2021}}</ref>


==Technology and products==
:'''Clinical diagnostics''': "From an industry and regulatory perspective, however, only the intended uses supported from the media manufacturer can be supported from AI applications, unless otherwise justified and substantive evidence is presented for additional claims support. This means strict adherence to specimen type and incubation conditions. Considering that the media was initially developed for human assessment using the well-trained microbiologist eye, and not an advanced imaging system with or without AI, this paradigm should shift to allow advancements in technology to challenge the status-quo of decreasing media read-times especially, as decreased read-times assist with laboratory turnaround times and thus patient management. Perhaps with an increasing body of evidence to support any proposed indications for use, either regulatory positions should be challenged, or manufacturers of media and industry AI-development specialists should work together to advance the field with new indications for use.
===ELab===
:While the use of AI in the laboratory setting can be highly beneficial there are still some issues to be addressed. The first being phenotypically distinct single organism polymorphisms that may be interpreted by AI as separate organisms, as may also be the case for a human assessment, as well as small colony variant categorization. As detailed earlier, the broader the inputs, the greater the generalization of the model, and the higher the likelihood of algorithm accuracy. In that respect, understanding and planning around these design constraints is critical for ultimate deployment of algorithms. Additionally, expecting an AI system to correctly categorize “contamination” is a difficult task as often this again seemingly innocuous decision is dependent on years of experience and understanding the specimen type and the full clinical picture with detailed clinical histories. In this respect, a fully integrated AI-LIS system where all data is available may assist, but it is currently not possible to gather this granular detail needed to make this assessment reliable."<ref name=":7" />
ELab is a hosted [[software as a service]] (SaaS) [[laboratory information management system]] (LIMS) + [[laboratory information system]] (LIS). Introduced in 2009 as webLIMS<ref name="webLIMS1" />, ELab "is a scalable system that can be configured to meet each lab’s unique needs."<ref name="ELabLimsNew">{{cite web |url=https://www.lablynx.com/lims-apps/elab-lims/ |title=LabLynx ELab LIMS |publisher=LabLynx, Inc |accessdate=25 February 2022}}</ref> The software can be hosted in the cloud or self-hosted. In April 2020, a COVID-19 testing module was developed for ELab that extends its molecular diagnostics and other related COVID-19 workflows.<ref name="PRNLabLynx20" /><ref name="LLXCovidElab">{{cite web |url=https://www.covidlims.com/elab-lims/ |title=ELab: The LiMS and Database at The Core of Lablynx’s COVIDLiMS Solution |publisher=LabLynx, Inc |accessdate=20 October 2020}}</ref>
:'''Clinical diagnostics and pathology''': "Well, if I’ve learned anything in my research into this topic, it’s that AI implementation needs to be a two-way street. First, any company who is active in this space must reach out to pathologists and laboratory medicine professionals to understand their daily workflows, needs, and pain points in as much detail as possible. Second, pathologists, laboratory medicine professionals, and educators must all play their important part – willingly offering their time and expertise when it is sought or proactively getting involved. And finally, it’s clear that there is an imbalanced focus on certain issues – with privacy, respect, and sustainability falling by the wayside."<ref name=":10">{{Cite web |last=Lee, G.F. |date=10 October 2022 |title=The Robot May See You Now: It’s time to stop and think about the ethics of artificial intelligence |work=The Pathologist |url=https://thepathologist.com/outside-the-lab/the-robot-may-see-you-now |accessdate=17 February 2023}}</ref>
 
:'''Healthcare''': "While we are encouraged by the promise shown by AI in healthcare, and more broadly welcome the use of digital technologies in improving clinical outcomes and health system productivity, we also recognize that caution must be exercised when introducing any new healthcare technology. Working with colleagues across the NHS Transformation Directorate, as well as the wider AI community, we have been developing a framework to evaluate AI-enabled solutions in the health and care policy context. The aim of the framework is several-fold but is, at its core, a tool with which to highlight to healthcare commissioners, end users, patients and members of the public the considerations to be mindful when introducing AI to healthcare settings."<ref>{{Cite journal |last=Chada |first=Bharadwaj V |last2=Summers |first2=Leanne |date=2022-10-10 |title=AI in the NHS: a framework for adoption |url=https://www.rcpjournals.org/lookup/doi/10.7861/fhj.2022-0068 |journal=Future Healthcare Journal |language=en |pages=fhj.2022–0068 |doi=10.7861/fhj.2022-0068 |issn=2514-6645 |pmc=PMC9761451 |pmid=36561823}}</ref>
===ELab LIMS for Cannabis===
:'''Most any lab''': A code of AI ethics should address objectivity, privacy, transparency, accountability, and sustainability in any AI implementation.<ref name=":10" />
ELab LIMS for Cannabis (formerly CannaQA LIMS<ref name="LLPWelcome19" />) is cloud-based LIMS software designed specifically for the cannabis testing industry, "with all of the features and functions required for cannabis testing, and can even come pre-loaded with the tests required by your local, state, and federal government, complete with required limit sets and methods."<ref name="LLXLIMSFor19">{{cite web |url=https://www.cannaqa.com/cannaqa-lims/ |title=LIMS for Cannabis Testing Laboratories |work=CannaQA |publisher=LabLynx, Inc |accessdate=01 February 2022}}</ref>
:'''Most any lab''': "Another approach is to implement an AI program alongside a manual process, assessing its performance along the way, as a means to ease into using the program. 'I think one of the most impactful things that laboratorians can do today is to help make sure that the lab data that they’re generating is as robust as possible, because these AI tools rely on new training sets, and their performance is really only going to be as good as the training data sets they’re given,' Stoffel said."<ref name=":8" />
 
===ClinDx===
ClinDx is hybrid LIMS-[[laboratory information system|LIS]] that "offers a unique blend of sample-focused and patient-focused workflows" that are adaptable to your laboratory.<ref name="LLXHealthcare">{{cite web |url=https://www.lablynx.com/industries/healthcare/ |title=Your Ideal Healthcare LIMS |publisher=LabLynx, Inc |accessdate=05 March 2022}}</ref>
 
===LabVia===
LabVia is a middleware hardware/software-based hub that "intelligently manages multiple data communications between all kinds of devices, services, systems or other sources."<ref name="LabVia">{{cite web |url=https://www.lablynx.com/eai/ |title=LabVia |publisher=LabLynx, Inc |accessdate=26 January 2018}}</ref>
 
====Product Features====
{{Ombox productfeature}}
 
{|
| STYLE="vertical-align:top;"|
{| class="wikitable collapsible" style="border-style:none;" background="#ffffff" border="0" cellpadding="0" cellspacing="0"
|-
  ! colspan="2"| Product: [https://www.lablynx.com/lims-apps/elab-lims/ ELab]
|-
  | style="background-color:white; border-style:none;"| {{Databox LIMSfeature
| sample_login_man  = Y<ref name="ELabLimsNew" />
| sample_track      = Y<ref name="ELabLimsNew" />
| sample_batch      = Y<ref name="ELabLimsNew" />
| task_event_sched  = Y<ref name="ELabLimsNew" />
| manual_entry      =
| multiple_view      =
| data_analysis      =
| data_sharing      =
| custom_fields      =
| query              =
| import_data        =
| data_linking_int  =
| data_linking_ext  =
| eln_support        =
| export_msexcel    =
| export_raw        =
| data_warehouse    =
| deadline_control  =
| production_control = Y<ref name="ELabLimsNew" />
| project_task_man  =
| inventory_man      = Y<ref name="ELabLimsNew" />
| document_man      = Y<ref name="ELabLimsNew" />
| case_man          =
| workflow_man      =
| spec_man          =
| customer_man      = Y<ref name="ELabLimsNew" />
| billing_man        = Y<ref name="ELabLimsNew" />
 
| reg_compliance    = Y<ref name="ELabLimsNew" />
| qa_qc              =
| performance_eval  =
| audit_trail        = Y<ref name="ELabLimsNew" />
| chain_custody      = Y<ref name="ELabLimsNew" />
| roles_security    =
| data_norm          =
| data_val          =
| data_encrypt      =
| version_control    =
| data_backup        =
| enviro_monitoring  =
 
| custom_reporting  = Y<ref name="ELabLimsNew" />
| report_printing    =
| label_support      =
| barcode_support    =
| export_pdf        =
| export_msword      =
| export_htmlxml    =
| fax_integration    = Y<ref name="ELabLimsNew" />
| email_integration  = Y<ref name="ELabLimsNew" />
 
| admin_manage      = Y<ref name="ELabLimsNew" />
| modular            =
| instrument_inter  = Y<ref name="ELabLimsNew" />
| mobile_device      =
| alarms_alerts      = Y<ref name="ELabLimsNew" />
| work_timetrack    =
| voice_rec          =
| external_monitor  = Y<ref name="ELabLimsNew" />
| messaging          =
| multilingual      = Y<ref name="ELabLimsNew" />
| network            =
| web_client        = Y<ref name="ELabLimsNew" />
| online_help        =
| saas_model        = Y<ref name="ELabLimsNew" />
| usage_cost        =
 
| industries        = agriculture, chemical, clinical diagnostics, clinical research, contract services, environmental, food and beverage, general, geology and mining, health care, high-throughput sequencing, law enforcement and forensic, manufacturing and R&D, material testing, medical device, molecular diagnostics, pathology, pharmaceutical, power and utility, public health and service, toxicology
}}
|-
|}
| STYLE="vertical-align:top; padding-right:10px;"|
{| class="wikitable collapsible" style="border-style:none;" background="#ffffff" border="0" cellpadding="0" cellspacing="0"
|-
  ! colspan="2"| Product: [https://www.cannaqa.com/applications/cannaqa-lims/ CannaQA LIMS]
|-
  | style="background-color:white; border-style:none;"| {{Databox LIMSfeature
| sample_login_man  = Y<ref name="LLXCannaQALIMS">{{cite web |url=https://www.cannaqa.com/applications/cannaqa-lims/ |title=LIMS for Cannabis Testing Laboratories |work=CannaQA |publisher=LabLynx, Inc |accessdate=02 March 2020}}</ref>
| sample_track      = Y<ref name="LLXCannaQALIMS" />
| sample_batch      = Y<ref name="LLXCannaQALIMS" />
| task_event_sched  = Y<ref name="LLXCannaQALIMS" />
| manual_entry      =
| multiple_view      = Y<ref name="LLXCannaQALIMS" />
| data_analysis      = Y<ref name="LLXCannaQALIMS" />
| data_sharing      =
| custom_fields      =
| query              = Y<ref name="LLXCannaQALIMS" />
| import_data        =
| data_linking_int  =
| data_linking_ext  =
| eln_support        =
| export_msexcel    = Y<ref name="LLXCannaQALIMS" />
| export_raw        =
| data_warehouse    = Y<ref name="LLXCannaQALIMS" />
| deadline_control  =
| production_control =
| project_task_man  =
| inventory_man      = Y<ref name="LLXCannaQALIMS" />
| document_man      = Y<ref name="LLXCannaQALIMS" />
| case_man          =
| workflow_man      = Y<ref name="LLXLIMSFor19" />
| spec_man          = Y<ref name="LLXCannaQALIMS" />
| customer_man      = Y<ref name="LLXCannaQALIMS" />
| billing_man        = Y<ref name="LLXCannaQALIMS" />
 
| reg_compliance    = Y<ref name="LLXCannaQALIMS" />
| qa_qc              = Y<ref name="LLXCannaQALIMS" />
| performance_eval  = Y<ref name="LLXCannaQALIMS" />
| audit_trail        = Y<ref name="LLXCannaQALIMS" />
| chain_custody      = Y<ref name="LLXLIMSFor19" />
| roles_security    = Y<ref name="LLXImplement">{{cite web |url=https://www.cannaqa.com/services/implementation/ |title=Implementation |work=CannaQA |publisher=LabLynx, Inc |accessdate=02 March 2020}}</ref>
| data_norm          =
| data_val          =
| data_encrypt      = Y<ref name="LLXCloud">{{cite web |url=https://www.cannaqa.com/services/cloud/ |title=Full Service Cloud Hosting & Security Solution |work=CannaQA |publisher=LabLynx, Inc |accessdate=02 March 2020}}</ref>
| version_control    =
| data_backup        = Y<ref name="LLXCloud" />
| enviro_monitoring  =
 
| custom_reporting  = Y<ref name="LLXCannaQALIMS" />
| report_printing    = Y<ref name="LLXCannaQALIMS" />
| label_support      = Y<ref name="LLXCannaQALIMS" />
| barcode_support    = Y<ref name="LLXCannaQALIMS" />
| export_pdf        =
| export_msword      =
| export_htmlxml    =
| fax_integration    =
| email_integration  = Y<ref name="LLXCannaQALIMS" />
 
| admin_manage      = Y<ref name="LLXCannaQALIMS" />
| modular            = Y<ref name="LLXCannaQALIMS" />
| instrument_inter  = Y<ref name="LLXCannaQALIMS" />
| mobile_device      =
| alarms_alerts      = Y<ref name="LLXCannaQALIMS" />
| work_timetrack    =
| voice_rec          =
| external_monitor  = Y<ref name="LLXCannaQALIMS" />
| messaging          =
| multilingual      =
| network            =
| web_client        =
| online_help        = Y<ref name="LLXCannaQALIMS" />
| saas_model        = Y<ref name="LLXCannaQALIMS" />
| usage_cost        =
 
| industries        = cannabis
}}
|-
|}
| STYLE="vertical-align:top; padding-right:10px;"|
{| class="wikitable collapsible" style="border-style:none;" background="#ffffff" border="0" cellpadding="0" cellspacing="0"
|-
  ! colspan="2"| Product: [https://www.lablynx.com/industries/healthcare/ ClinDx]
|-
  | style="background-color:white; border-style:none;"| {{Databox LISfeature
| sample_login_man  = Y<ref name="LLXHealthcare" />
| sample_track      =
| sample_batch      = Y<ref name="LLXHealthcare" />
| task_event_sched  =
| manual_entry      =
| multiple_view      =
| custom_temps_forms =
| data_analysis      =
| data_sharing      =
| data_mining        =
| custom_fields      =
| query              =
| import_data        =
| data_linking_int  =
| data_linking_ext  =
| eln_support        =
| export_msexcel    =
| export_raw        =
| data_warehouse    =
| project_task_man  =
| exp_trial_man      =
| inventory_man      =
| doc_image_man      = Y<ref name="LLXHealthcare" />
| pat_case_man      = Y<ref name="LLXHealthcare" />
| workflow_man      =
| spec_man          =
| customer_man      = Y<ref name="LLXHealthcare" />
| billing_rev_man    = Y<ref name="LLXHealthcare" />
 
| reg_compliance    = Y<ref name="LLXHealthcare" />
| qa_qc              =
| performance_eval  =
| audit_trail        =
| chain_custody      =
| roles_security    =
| data_norm          =
| data_val          =
| data_encrypt      =
| version_control    =
| data_backup        =
| enviro_monitoring  =
 
| custom_reporting  =
| syn_reporting      =
| report_printing    =
| label_support      =
| bc_rfid_support    =
| export_pdf        =
| export_msword      =
| export_htmlxml    =
| fax_integration    =
| email_integration  =
 
| admin_manage      =
| modular            =
| instrument_inter  = Y<ref name="LLXHealthcare" />
| mobile_device      =
| soft_integration  = Y<ref name="LLXHealthcare" />
| alarms_alerts      =
| work_timetrack    =
| voice_rec          =
| external_monitor  = Y<ref name="LLXHealthcare" />
| messaging          =
| commenting        =
| multilingual      =
| network            =
| web_client        =
| online_help        =
| saas_model        =
| usage_cost        =
 
| industries        = clinical, general, genomics and molecular diagnostics, public health and service, toxicology
}}
|-
|}
|}
 
===Pricing===
====ELab and its add-on LIMS applications====
Source for pricing information is directly from LabLynx. Additional pricing information can be gleaned from [https://www.gsaadvantage.gov/ref_text/GS35F511DA/0VZ7MY.3RPKLP_GS-35F-511DA_GS35F511DAIFSS600LABLYNX.PDF GSA Avantage]. As prices may change at any time, always contact the vendor directly to obtain a price list or quote.
 
{|
| STYLE="vertical-align:top;"|
{| class="wikitable collapsible" border="1" cellpadding="5" cellspacing="0"
|-
  ! style="background-color:#ccc;" colspan="4"| ELab and Related Add-on LIMS Price List
|-
  | style="background-color:#ddd; text-align:center;" colspan="4"|'''LIMS Licensing'''
|-
  ! style="background-color:#eee;" rowspan="2"| ELab, ClinDx, and other LIMS
  ! style="background-color:#eee;" colspan="2"| Subscription
  ! style="background-color:#eee;" rowspan="2"| Perpetual
|-
  ! style="background-color:#eee;"| # of users
  ! style="background-color:eee;"| Price/user/yr
|-
  | rowspan="4"|
  | style="background-color:white;" |2
  | style="background-color:white;" |$3,000
  | style="background-color:white;" rowspan="4" |$30,000 (includes 5 licenses)
|-
  | style="background-color:white;" |3–9
  | style="background-color:white;" |$2,250
|-
  | style="background-color:white;" |10–14
  | style="background-color:white;" |$1,950
|-
  | style="background-color:white;" |15+
  | style="background-color:white;" |$1,800
|-
  | '''License types'''
  | style="background-color:white;" colspan="2"|Concurrent / Subscription
  | style="background-color:white;" |Concurrent / Purchased
|-
  | '''Additional licenses'''<br />(each additional concurrent user)
  | style="background-color:white; " colspan="2"|Based on table above
  | style="background-color:white;" |$5,000
|-
  | '''Implementation services'''
  | style="background-color:white;" colspan="2"|Quote
  | style="background-color:white;" |Quote
|-
  | style="background-color:#ddd; text-align:center;" colspan="4"|'''LIMS Service Plan'''
|-
  ! style="background-color:#eee;"|  
  ! style="background-color:#eee;" colspan="2"| Subscription
  ! style="background-color:#eee;"| Perpetual
|-
  | '''Status'''
  | style="background-color:white;" colspan="2"|'''Included'''
  | style="background-color:white;" |'''Optional'''
|-
  | '''Annual fee'''
  | style="background-color:white;" colspan="2"|Included
  | style="background-color:white;" |20% of license fee
|-
  | '''Self-hosting fee'''
  | style="background-color:white;" colspan="2"|N/A
  | style="background-color:white;" |$4,500/year
|-
  | '''Maintenance'''
  | style="background-color:white;" colspan="2"|Yes
  | style="background-color:white;" |Yes
|-
  | '''Warranty'''
  | style="background-color:white;" colspan="2"|Yes
  | style="background-color:white;" |Yes
|-
  | style="background-color:#ddd; text-align:center;" colspan="4"|'''LabVia Interfacing Module'''
|- 
  | '''LabVia Pi'''
  | style="background-color:white; text-align:center;" colspan="3"|$150 each
|-
  | '''LabVia Serial'''
  | style="background-color:white; text-align:center;" colspan="3"|$150 each
|-
  | style="background-color:#ddd; text-align:center;" colspan="4"|'''LabVia Service Plan'''
|-
  | '''Status'''
  | style="background-color:white; text-align:center;" colspan="3"|'''Optional'''
|-
  | '''Fee''' (if LabVia interface selected)
  | style="background-color:white; text-align:center;" colspan="3"|$100/month or $1,000/yr
|-
  | '''Maintenance'''
  | style="background-color:white; text-align:center;" colspan="3"|Yes
|-
  | '''Warranty'''
  | style="background-color:white; text-align:center;" colspan="3"|Yes
|-
  | style="background-color:#ddd; text-align:center;" colspan="4"|'''Add-on Applications'''
|-
  | '''License type'''
  | style="background-color:white; text-align:center;" colspan="3"|Open-source
|-
  | '''License included'''
  | style="background-color:white; text-align:center;" colspan="3"|Unlimited
|-
  | '''Pricing'''
  | style="background-color:white; text-align:center;" colspan="3"|Quote
|-
  | style="background-color:#ddd; text-align:center;" colspan="4"|'''Other Services'''
|-
  | '''Additional hours'''<br />(as needed/requested)
  | style="background-color:white; text-align:center;" colspan="3"|$175/hour
|-
|}
|}
 
====CannaQA====
Source for pricing information is directly from LabLynx.<ref name="LLXUnitPrice">{{cite web |url=https://www.cannaqa.com/ebook/cannaqa-catalog-price-list/ |title=CannaQA Catalog & Price List: The complete cannabis testing solution and community |work=CannaQA |publisher=LabLynx, Inc |accessdate=01 February 2022}}</ref> The software can be licensed as an annual subscription or purchased.
 
'''Subscription'''
 
* Up to two concurrent users at $6,000 per year ($3,000 annual price per user)
* Three to nine concurrent users at $6,750 - $20,250 ($2,250 annual price per user)
* 10 to 14 concurrent users at $19,500 - $27,300 ($1,950 annual price per user)
* 15 to 50+ concurrent users at $27,000 - $90,000+ ($1,800 annual price per user)
 
'''Purchased'''
 
* Core CannaQA LIMS module and implementation: Everything needed to analyze, track, and report cannabis samples is included; however, many processes are manual, and things like tests must be created by the user (training is provided) - $20,500
 
'''Add-ons'''
 
* CannaQA Lab Portal, a client-facing web portal: $$5,000
 
Other fees include $175/hour for project management, acceptance testing, training, etc. See the [https://www.cannaqa.com/ebook/cannaqa-catalog-price-list/ CannaQA website] for the various options and their prices.
 
===Demonstration videos and other media===
The following demonstration videos are available for ELab:
 
* [https://vimeo.com/521128225 ELab - The Comprehensive Cloud-Based LIMS Platform]
* [https://vimeo.com/440072887 COVIDLiMS - The LabLynx COVIDLiMS Solution Suite]
* [https://vimeo.com/430454688 C-SICKIT - COVID19 Sample Information Collection Kit]
* [https://vimeo.com/493758567 COVIDLiMS for Research Laboratories]
* [https://vimeo.com/492209702 COVIDLiMS for Environmental and Wastewater Labs]
* [https://vimeo.com/488978267 COVIDLiMS for Industrial Hygiene/Occupational Health and Safety]
* [https://vimeo.com/487250746 COVIDLiMS for Mobile Testing]
* [https://vimeo.com/486156110 COVIDLiMS for Nursing Homes]
* [https://vimeo.com/484620722 COVIDLiMS for Workplace Testing]
* [https://vimeo.com/482821897 COVIDLiMS for Reference Labs]
* [https://vimeo.com/481448440 COVIDLiMS for Clinics and POLs]
* [https://vimeo.com/478967938 COVIDLiMS for Schools and Universities]
* [https://vimeo.com/477247890 COVIDLiMS for Public Health]
* [https://vimeo.com/442485936 myLabCare - HIPAA-Compliant Cloud-Hosted Physician Portal]
* [https://vimeo.com/424764673 LabVia - Integrate, Automate, Monitor ... Everything]
* [https://vimeo.com/336905513 CannaQA LIMS]
 
===Additional information===
 
 
==External links==
* [https://www.lablynx.com/ Official website]
* [https://www.limsforum.com/ LIMSforum community portal]
* [https://www.limswiki.org/ LIMSwiki site]
* [https://www.cannaqa.wiki/ CannaQAwiki site]
* [https://vimeo.com/lablynx LabLynx on Vimeo]
* [https://www.youtube.com/user/lablynx LabLynx on YouTube]


==References==
==References==
{{Reflist|colwidth=30em}}
{{Reflist|colwidth=30em}}
<!---Place all category tags here-->
[[Category:Agriculture LIMS]]
[[Category:Cannabis LIMS]]
[[Category:Chemical LIMS]]
[[Category:Clinical LIS]]
[[Category:Clinical diagnostics LIMS]]
[[Category:Clinical research LIMS]]
[[Category:Cloud-based LIMS]]
[[Category:Cloud-based LIS]]
[[Category:Contract services LIMS]]
[[Category:Environmental LIMS]]
[[Category:Food and beverage LIMS]]
[[Category:General LIMS]]
[[Category:General LIS]]
[[Category:Genomics and molecular diagnostics LIS]]
[[Category:Geology and mining LIMS]]
[[Category:Health care LIMS]]
[[Category:High-throughput sequencing LIMS]]
[[Category:LabLynx KB:Articles]]
[[Category:LabLynx, Inc.]]
[[Category:Law enforcement and forensic LIMS]]
[[Category:LIMS vendor]]
[[Category:LIS vendor]]
[[Category:Manufacturing and R&D LIMS]]
[[Category:Material testing LIMS]]
[[Category:Medical device LIMS]]
[[Category:Middleware vendor]]
[[Category:Molecular diagnostics LIMS]]
[[Category:Pathology LIMS]]
[[Category:Pharmaceutical LIMS]]
[[Category:Power and utility LIMS]]
[[Category:Public health and service LIMS]]
[[Category:Public health and service LIS]]
[[Category:Toxicology LIMS]]
[[Category:Toxicology LIS]]

Latest revision as of 19:33, 17 February 2023

Sandbox begins below

  • Discussion and practical use of artificial intelligence (AI) in the laboratory is, perhaps to the surprise of some, not a recent phenomena. In the mid-1980s, researchers were developing computerized AI systems able "to develop automatic decision rules for follow-up analysis of [clinical laboratory] tests depending on prior information, thus avoiding the delays of traditional sequential testing and the costs of unnecessary parallel testing."[1] In fact, discussion of AI in general was ongoing even in the mid-1950s.[2][3]
  • Hiring demand for laboratorians with AI experience (2015–18) has historically been higher in non-healthcare industries, such as manufacturing, mining, and agriculture, shedding a light on how AI adoption in the clinical setting may be lacking. According to the Brookings Institute, "Even for the relatively-skilled job postings in hospitals, which includes doctors, nurses, medical technicians, research lab workers, and managers, only approximately 1 in 1,250 job postings required AI skills." They add: "AI adoption may be slow because it is not yet useful, or because it may not end up being as useful as we hope. While our view is that AI has great potential in health care, it is still an open question."[4]
  • Today, AI is being practically used in not only clinical diagnostic laboratories but also clinical research labs, life science labs, and research and development (R&D) labs, and more. Practical uses of AI can be found in:
clinical research labs[5]
hospitals[5][6]
medical diagnostics labs[6][7][8][9][10][11]
chromatography labs[11]
biology and life science labs[12]
medical imaging centers[13]
ophthalmology clinics[14]
reproduction clinics[15][16][17]
digital pathology labs[18]
material testing labs[19][20][21]
chemical experimentation and molecular discovery labs[21][22][23]
quantum physics labs[24]
  • What's going on in these labs?
Materials science: The creation of "a modular robotic platform driven by a model-based optimization algorithm capable of autonomously optimizing the optical and electronic properties of thin-film materials by modifying the film composition and processing conditions ..."[19]
Materials science: "Most of the applications of [machine learning (ML)] in chemical and materials sciences, as we have said, feature supervised learning algorithms. The goal there is to supplement or replace traditional modeling methods, at the quantum chemical or classical level, in order to predict the properties of molecules or materials directly from their structure or their chemical composition ... Our research group was applying the same idea on a narrower range of materials, trying to confirm that for a given chemical composition, geometrical descriptors of a material’s structure could lead to accurate predictions of its mechanical features."[20]
Life science: "In biological experiments, we generally cannot as easily declare victory, but we can use the systems biology approach of cycling between experimentation and modelling to see which sequences, when tested, are most likely to improve the model. In artificial intelligence, this is called active learning, and it has some similarity to the way in which we as humans learn as infants: we get some help from parents and teachers, but mainly model the world around us by exploring it and interacting with it. Ideally then, we would recreate such an environment for our machine learning algorithms in the laboratory, where we start with an initial ‘infant’ model of a certain regulatory system or protein function and let the computer decide what sequence designs to try out – a deep learning version of the ‘robot scientist’. Microbes are ideal organisms for such an approach, given the ease and speed with which they can be grown and genetically manipulated. Combined with laboratory automation, many microbial experiments can (soon) be performed with minimal human intervention, ranging from strain construction and screening, such as operated by Amyris, Gingko, Transcriptic, etc., to full-genome engineering or even the design of microbial ecologies."[12]
Digital pathology: "The collaboration combines two AI solutions, VistaPath’s Sentinel, the world’s first automated tissue grossing platform, and Gestalt’s AI Requisition Engine (AIRE), a leading-edge AI algorithm for accessioning, to raise the bar in AI-driven pathology digitization. Designed to make tissue grossing faster and more accurate, VistaPath’s Sentinel uses a high-quality video system to assess specimens and create a gross report 93% faster than human technicians with 43% more accuracy. It not only improves on quality by continuously monitoring the cassette, container, and tissue to reduce mislabeling and specimen mix-up, but also increases traceability by retaining original images for downstream review."[25]
Chemistry and molecular science: "The benefits of combining automated experimentation with a layer of artificial intelligence (AI) have been demonstrated for flow reactors, photovoltaic films, organic synthesis, perovskites and in formulation problems. However, so far no approaches have integrated mobile robotics with AI for chemical experiments. Here, we built Bayesian optimization into a mobile robotic workflow to conduct photocatalysis experiments within a ten-dimensional space."[22]
Chemistry and immunology: "Chemistry and immunology laboratories are particularly well-suited to leverage machine learning because they generate large, highly structured data sets, Schulz and others wrote in a separate review paper. Labor-intensive processes used for interpretation and quality control of electrophoresis traces and mass spectra could benefit from automation as the technology improves, they said. Clinical chemistry laboratories also generate digital images—such as urine sediment analysis—that may be highly conducive to semiautomated analyses, given advances in computer vision, the paper noted."[26]
Clinical research: "... retrospective analysis of existing patient data for descriptive and clustering purposes [and] automation of knowledge extraction, ranging from text mining, patient selection for trials, to generation of new research hypotheses ..."[5]
Clinical research: "AI ... offers a further layer to the laboratory system by analyzing all experimental data collected by experiment devices, whether it be a sensor or a collaborative robot. From data collected, AI is able to produce hypotheses and predict which combination of materials or temperature is desired for the experiment. In short, this system will allow scientists to be aided by a highly intelligent system which is constantly monitoring and analyzing the experimental output. In this way, AI will help an experiment from its inception to conclusion."[27]
Clinical research/medical diagnostics: "Artificial intelligence (AI) in the laboratory is primarily used to make sense of big data, the almost impossibly large sets of data that biologists and pharmaceutical R&D teams are accustomed to working with. AI algorithms can parse large amounts of data in a short amount of time and turn that data into visualizations that viewers can easily understand. In certain data-intensive fields, such as genomic testing and virus research, AI algorithms are the best way to sort through the data and do some of the pattern recognition work."[28]
Medical diagnostics: Development and implementation of clinical decision support systems [5][6]
Medical diagnostics: "Finally, in the laboratory, AI reduces the number of unnecessary blood samples when diagnosing infection. Instead of the 'gold standard blood sample' that takes 24-72 hours, the algorithm can predict the outcome of the blood sample with almost 80% accuracy based on demographics, vital signs, medications, and laboratory and radiology results. These are all examples of how Artificial Intelligence can be used to test better and faster with information that already exists. This saves time and costs."[10]
Medical diagnostics: "Chang sees two overarching classes of AI models: those that tackle internal challenges in the lab, such as how to deliver more accurate results to clinicians; and those that seek to identify cohorts of patients and care processes to close quality gaps in health delivery systems. The lab, however, 'isn’t truly an island,' said Michelle Stoffel, MD, PhD, associate chief medical information officer for laboratory medicine and pathology at M Health Fairview and the University of Minnesota in Minneapolis. 'When other healthcare professionals are working with electronic health records or other applications, there could be AI-driven tools, or algorithms used by an institution’s systems that may draw on laboratory data.'"[26]
Medical diagnostics: AI is used for the formulation of reference ranges, improvement of quality control, and automated interpretation of results. "Continuous monitoring of specimen acceptability, collection and transport can result in the prompt identification and correction of problems, leading to improved patient care and a reduction in unnecessary redraws and delays in reporting results."[8]
Reproduction science: "The field of AI is the marriage of humans and computers while reproductive medicine combines clinical medicine and the scientific laboratory of embryology. The application of AI has the potential to disconnect healthcare professionals from patients through algorithms, automated communication, and clinical imaging. However, in the embryology laboratory, AI, with its focus on gametes and embryos, can avoid the same risk of distancing from the patient. Areas of application of AI in the laboratory would be to enhance and automate embryo ranking through analysis of images, the ultimate goal being to predict successful implantation. Might such a trend obviate the need for embryo morphological assessment, time-lapse imaging and preimplantation genetic testing for aneuploidy (PGT-A), including mosaicism. Additionally, AI could assist with automation through analysis of testicular sperm samples searching for viable gametes, embryo grading uniformity."[15]
Chromatography-heavy sciences: " A great example of this is AI in the Liquid Chromatography Mass Spectrometry (LC-MS) field. LC-MS is a great tool used to measure various compounds in the human body, including everything from hormone levels to trace metals. One of the ways AI has already integrated with LC-MS is how it cuts down on the rate limiting steps of LC-MS, which more often than not are sample prep and LC separations. One system that Physicians Lab has made use of is parallel processing using SCIEX MPX 2.0 High Throughput System. This system can couple parallel runs with one LCMS instrument, resulting in twice the speed with no loss to accuracy. It can do this by staggering two runs either using the same method, or different methods entirely. What really makes this system great is its ability to automatically detect carryover and inject solvent blanks to clean the instrument. The system will then continue its analyzing, while automatically reinjecting samples that may be affected by the carryover. It will also flag high concentration without user input, allowing for easy detection of possibly faulty samples. This allows it to operate without users from startup to shut down. Some of the other ways that it can be used to increase efficiency are by using integrated network features to work on anything from streamlining management to increased throughput."[11]
Most any lab: "Predictive analytics, for example, is one tool that the Pistoia Alliance is using to better understand laboratory instruments and how they might fail over time... With the right data management strategies and careful consideration of metadata, how to best store data so that it can be used in future AI and ML workflows is essential to the pursuit of AI in the laboratory. Utilizing technologies such as LIMS and ELN enables lab users to catalogue data, providing context and instrument parameters that can then be fed into AI or ML systems. Without the correct data or with mismatched data types, AI and ML will not be possible, or at the very least, could provide undue bias trying to compare data from disparate sources."[29]
Most any lab: "When the actionable items are automatically created by Optima, the 'engine' starts working. An extremely sophisticated algorithm is able to assign the tasks to the resources, both laboratory personnel and instruments, according to the system configuration. Optima, thanks to a large amount of time dedicated to research the best way to automate this critical process, is able to automate most of the lab resource scheduling."[30]
  • A number of challenges exist in the realm of effectively and securely implementing AI in the laboratory. This includes:
Ethical and privacy challenges[5][26][31]
Algorithmic limitations[4]
Data access limitations, including "where to get it, how to share it, and how to know when you have enough to train a machine-learning system that will produce good results"[4][26][32][33]
Data integration and transformation issues[5][33]
Regulatory barriers[4][7]
Misaligned incentives[4]
Lack of knowledgeable/skilled talent[5][26][32][33]
Cost of skilled talent and infrastructure for maintaining and updating AI systems[26]
Legacy systems running outdated technologies[32]
Lack of IT systems or specialized software systems[33]
Lack of standardized, best practices-based methods of validating algorithms[26]
Failure to demonstrate real-world performance[7]
Failure to meet the needs of the professionals using it[7]
  • Given those challenges, some considerations should be made about implementing AI-based components in the laboratory. Examples include:
Clinical diagnostics: "From an industry and regulatory perspective, however, only the intended uses supported from the media manufacturer can be supported from AI applications, unless otherwise justified and substantive evidence is presented for additional claims support. This means strict adherence to specimen type and incubation conditions. Considering that the media was initially developed for human assessment using the well-trained microbiologist eye, and not an advanced imaging system with or without AI, this paradigm should shift to allow advancements in technology to challenge the status-quo of decreasing media read-times especially, as decreased read-times assist with laboratory turnaround times and thus patient management. Perhaps with an increasing body of evidence to support any proposed indications for use, either regulatory positions should be challenged, or manufacturers of media and industry AI-development specialists should work together to advance the field with new indications for use.
While the use of AI in the laboratory setting can be highly beneficial there are still some issues to be addressed. The first being phenotypically distinct single organism polymorphisms that may be interpreted by AI as separate organisms, as may also be the case for a human assessment, as well as small colony variant categorization. As detailed earlier, the broader the inputs, the greater the generalization of the model, and the higher the likelihood of algorithm accuracy. In that respect, understanding and planning around these design constraints is critical for ultimate deployment of algorithms. Additionally, expecting an AI system to correctly categorize “contamination” is a difficult task as often this again seemingly innocuous decision is dependent on years of experience and understanding the specimen type and the full clinical picture with detailed clinical histories. In this respect, a fully integrated AI-LIS system where all data is available may assist, but it is currently not possible to gather this granular detail needed to make this assessment reliable."[9]
Clinical diagnostics and pathology: "Well, if I’ve learned anything in my research into this topic, it’s that AI implementation needs to be a two-way street. First, any company who is active in this space must reach out to pathologists and laboratory medicine professionals to understand their daily workflows, needs, and pain points in as much detail as possible. Second, pathologists, laboratory medicine professionals, and educators must all play their important part – willingly offering their time and expertise when it is sought or proactively getting involved. And finally, it’s clear that there is an imbalanced focus on certain issues – with privacy, respect, and sustainability falling by the wayside."[31]
Healthcare: "While we are encouraged by the promise shown by AI in healthcare, and more broadly welcome the use of digital technologies in improving clinical outcomes and health system productivity, we also recognize that caution must be exercised when introducing any new healthcare technology. Working with colleagues across the NHS Transformation Directorate, as well as the wider AI community, we have been developing a framework to evaluate AI-enabled solutions in the health and care policy context. The aim of the framework is several-fold but is, at its core, a tool with which to highlight to healthcare commissioners, end users, patients and members of the public the considerations to be mindful when introducing AI to healthcare settings."[34]
Most any lab: A code of AI ethics should address objectivity, privacy, transparency, accountability, and sustainability in any AI implementation.[31]
Most any lab: "Another approach is to implement an AI program alongside a manual process, assessing its performance along the way, as a means to ease into using the program. 'I think one of the most impactful things that laboratorians can do today is to help make sure that the lab data that they’re generating is as robust as possible, because these AI tools rely on new training sets, and their performance is really only going to be as good as the training data sets they’re given,' Stoffel said."[26]

References

  1. Berger-Hershkowitz, H.; Neuhauser, D. (1987). "Artificial intelligence in the clinical laboratory". Cleveland Clinic Journal of Medicine 54 (3): 165–166. doi:10.3949/ccjm.54.3.165. ISSN 0891-1150. PMID 3301059. https://www.ccjm.org/content/54/3/165. 
  2. Minsky, M. (17 December 1956). Heuristic Aspects of the Artificial Intelligence Problem. Ed Services Technical Information Agency. https://books.google.com/books?hl=en&lr=&id=fvWNo6_IZGUC&oi=fnd&pg=PA1. Retrieved 16 February 2023. 
  3. Minsky, Marvin (1 January 1961). "Steps toward Artificial Intelligence". Proceedings of the IRE 49 (1): 8–30. doi:10.1109/JRPROC.1961.287775. ISSN 0096-8390. http://ieeexplore.ieee.org/document/4066245/. 
  4. 4.0 4.1 4.2 4.3 4.4 Goldfarb, A.; Teodoridis, F. (9 March 2022). "Why is AI adoption in health care lagging?". Series: The Economics and Regulation of Artificial Intelligence and Emerging Technologies. Brookings Institute. https://www.brookings.edu/research/why-is-ai-adoption-in-health-care-lagging/. Retrieved 17 February 2023. 
  5. 5.0 5.1 5.2 5.3 5.4 5.5 5.6 Damiani, A.; Masciocchi, C.; Lenkowicz, J.; Capocchiano, N. D.; Boldrini, L.; Tagliaferri, L.; Cesario, A.; Sergi, P. et al. (7 December 2021). "Building an Artificial Intelligence Laboratory Based on Real World Data: The Experience of Gemelli Generator". Frontiers in Computer Science 3: 768266. doi:10.3389/fcomp.2021.768266. ISSN 2624-9898. https://www.frontiersin.org/articles/10.3389/fcomp.2021.768266/full. 
  6. 6.0 6.1 6.2 University of California, San Francisco; Adler-Milstein, Julia; Aggarwal, Nakul; University of Wisconsin-Madison; Ahmed, Mahnoor; National Academy of Medicine; Castner, Jessica; Castner Incorporated et al. (29 September 2022). "Meeting the Moment: Addressing Barriers and Facilitating Clinical Adoption of Artificial Intelligence in Medical Diagnosis". NAM Perspectives 22 (9). doi:10.31478/202209c. PMC PMC9875857. PMID 36713769. https://nam.edu/meeting-the-moment-addressing-barriers-and-facilitating-clinical-adoption-of-artificial-intelligence-in-medical-diagnosis. 
  7. 7.0 7.1 7.2 7.3 Government Accountability Office (GAO); National Academy of Medicine (NAM) (September 2022). "Artificial Intelligence in Health Care: Benefits and Challenges of Machine Learning Technologies for Medical Diagnostics" (PDF). Government Accountability Office. https://www.gao.gov/assets/gao-22-104629.pdf. Retrieved 16 February 2023. 
  8. 8.0 8.1 Wen, Xiaoxia; Leng, Ping; Wang, Jiasi; Yang, Guishu; Zu, Ruiling; Jia, Xiaojiong; Zhang, Kaijiong; Mengesha, Birga Anteneh et al. (24 September 2022). "Clinlabomics: leveraging clinical laboratory data by data mining strategies" (in en). BMC Bioinformatics 23 (1): 387. doi:10.1186/s12859-022-04926-1. ISSN 1471-2105. PMC PMC9509545. PMID 36153474. https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-022-04926-1. 
  9. 9.0 9.1 DeYoung, B.; Morales, M.; Giglio, S. (4 August 2022). "Microbiology 2.0–A “behind the scenes” consideration for artificial intelligence applications for interpretive culture plate reading in routine diagnostic laboratories". Frontiers in Microbiology 13: 976068. doi:10.3389/fmicb.2022.976068. ISSN 1664-302X. PMC PMC9386241. PMID 35992715. https://www.frontiersin.org/articles/10.3389/fmicb.2022.976068/full. 
  10. 10.0 10.1 Schut, M. (1 December 2022). "Get better with bytes". Amsterdam UMC. https://www.amsterdamumc.org/en/research/news/get-better-with-bytes.htm. Retrieved 16 February 2023. 
  11. 11.0 11.1 11.2 Albano, V.; Morris, C.; Kent, T. (6 December 2019). "Calculations to Diagnosis: The Artificial Intelligence Shift That’s Already Happening". Physicians Lab. https://physicianslab.com/calculations-to-diagnosis-the-artificial-intelligence-shift-thats-already-happening/. Retrieved 16 February 2023. 
  12. 12.0 12.1 de Ridder, Dick (1 January 2019). "Artificial intelligence in the lab: ask not what your computer can do for you" (in en). Microbial Biotechnology 12 (1): 38–40. doi:10.1111/1751-7915.13317. PMC PMC6302702. PMID 30246499. https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.13317. 
  13. Brandao-de-Resende, C.; Bui, M.; Daneshjou, R. et al. (11 October 2022). "AI Webinar: Clinical Adoption of AI Across Image Producing Specialties". Society for Imaging Informatics in Medicine. https://siim.org/page/22w_clinical_adoption_of_ai. 
  14. He, Mingguang; Li, Zhixi; Liu, Chi; Shi, Danli; Tan, Zachary (1 July 2020). "Deployment of Artificial Intelligence in Real-World Practice: Opportunity and Challenge" (in en). Asia-Pacific Journal of Ophthalmology 9 (4): 299–307. doi:10.1097/APO.0000000000000301. ISSN 2162-0989. https://journals.lww.com/10.1097/APO.0000000000000301. 
  15. 15.0 15.1 Trolice, Mark P.; Curchoe, Carol; Quaas, Alexander M (1 July 2021). "Artificial intelligence—the future is now" (in en). Journal of Assisted Reproduction and Genetics 38 (7): 1607–1612. doi:10.1007/s10815-021-02272-4. ISSN 1058-0468. PMC PMC8260235. PMID 34231110. https://link.springer.com/10.1007/s10815-021-02272-4. 
  16. European Society of Human Reproduction and Embryology (6 July 2022). "Annual Meeting 2022: Artificial intelligence in embryology and ART". Focus on Reproduction. https://www.focusonreproduction.eu/article/ESHRE-News-22AI. Retrieved 16 February 2023. 
  17. Hinckley, M. (17 March 2021). "Applying AI (Artificial Intelligence) in the Lab for Better IVF Success". Reproductive Science Center Blog. Reproductive Science Center of the Bay Area. https://rscbayarea.com/blog/applying-ai-for-better-ivf-success. Retrieved 16 February 2023. 
  18. Yousif, M.; McClintock, D.S.; Yao, K. (2021). "Artificial intelligence is the key driver for digital pathology adoption". Clinical Laboratory Int. PanGlobal Media. https://clinlabint.com/artificial-intelligence-is-the-key-driver-for-digital-pathology-adoption/. Retrieved 16 February 2023. 
  19. 19.0 19.1 MacLeod, B. P.; Parlane, F. G. L.; Morrissey, T. D.; Häse, F.; Roch, L. M.; Dettelbach, K. E.; Moreira, R.; Yunker, L. P. E. et al. (15 May 2020). "Self-driving laboratory for accelerated discovery of thin-film materials" (in en). Science Advances 6 (20): eaaz8867. doi:10.1126/sciadv.aaz8867. ISSN 2375-2548. PMC PMC7220369. PMID 32426501. https://www.science.org/doi/10.1126/sciadv.aaz8867. 
  20. 20.0 20.1 Chibani, Siwar; Coudert, François-Xavier (1 August 2020). "Machine learning approaches for the prediction of materials properties" (in en). APL Materials 8 (8): 080701. doi:10.1063/5.0018384. ISSN 2166-532X. http://aip.scitation.org/doi/10.1063/5.0018384. 
  21. 21.0 21.1 Mullin, R. (28 March 2021). "The lab of the future is now". Chemical & Engineering News 99 (11). Archived from the original on 06 May 2022. https://web.archive.org/web/20220506192926/http://cen.acs.org/business/informatics/lab-future-ai-automated-synthesis/99/i11. Retrieved 16 February 2023. 
  22. 22.0 22.1 Burger, Benjamin; Maffettone, Phillip M.; Gusev, Vladimir V.; Aitchison, Catherine M.; Bai, Yang; Wang, Xiaoyan; Li, Xiaobo; Alston, Ben M. et al. (9 July 2020). "A mobile robotic chemist" (in en). Nature 583 (7815): 237–241. doi:10.1038/s41586-020-2442-2. ISSN 0028-0836. https://www.nature.com/articles/s41586-020-2442-2.epdf?sharing_token=HOkIS6P5VIAo2_l3nRELmdRgN0jAjWel9jnR3ZoTv0Nw4yZPDO1jBpP52iNWHbb8TakOkK906_UHcWPTvNxCmzSMpAYlNAZfh29cFr7WwODI2U6eWv38Yq2K8odHCi-qwHcEDP18OjAmH-0KgsVgL5CpoEaQTCvbmhXDSyoGs6tIMe1nuABTeP58z6Ck3uULcdCtVQ66X244FsI7uH8GnA%3D%3D&tracking_referrer=cen.acs.org. 
  23. Lemonick, S. (6 April 2020). "Exploring chemical space: Can AI take us where no human has gone before?". Chemical & Engineering News 98 (13). Archived from the original on 29 July 2020. https://web.archive.org/web/20200729004137/https://cen.acs.org/physical-chemistry/computational-chemistry/Exploring-chemical-space-AI-take/98/i13. Retrieved 16 February 2023. 
  24. Doctrow, B. (16 December 2019). "Artificial intelligence in the laboratory". PNAS Science Sessions. https://www.pnas.org/post/podcast/artificial-intelligence-laboratory. Retrieved 16 February 2023. 
  25. VistaPath (28 July 2022). "VistaPath Launches New Collaboration with Gestalt Diagnostics to Further Accelerate Pathology Digitization". PR Newswire. Cision US Inc. https://www.prnewswire.com/news-releases/vistapath-launches-new-collaboration-with-gestalt-diagnostics-to-further-accelerate-pathology-digitization-301594718.html. Retrieved 17 February 2023. 
  26. 26.0 26.1 26.2 26.3 26.4 26.5 26.6 26.7 Blum, K. (1 January 2023). "A Status Report on AI in Laboratory Medicine". Clinical Laboratory News. American Association for Clinical Chemistry. https://www.aacc.org/cln/articles/2023/janfeb/a-status-report-on-ai-in-laboratory-medicine. Retrieved 17 February 2023. 
  27. Chubb, P. (3 November 2020). "How disruptive technology is helping laboratories combat COVID-19". Datafloq. https://datafloq.com/read/disruptive-technologies-lab-help-us-prepare-future-pandemics/. Retrieved 16 February 2023. 
  28. Stewart, B. (18 March 2021). "Using LIMS for Data Visualization". CSols Insights. CSols, Inc. https://www.csolsinc.com/insights/published-articles/using-lims-for-data-visualization/. Retrieved 17 February 2023. 
  29. "Data Analytics". Scientific Computing World - Building a Smart Laboratory 2020. Europa Science Ltd. 29 January 2021. https://www.scientific-computing.com/feature/data-analytics-0. Retrieved 17 February 2023. 
  30. Optima Team (15 December 2020). "The concept of machine learning applied to lab resources scheduling". Optima Blog. Optima PLC Tracking Tools S.L. https://www.optima.life/blog/the-concept-of-machine-learning-applied-to-lab-resources-scheduling/. Retrieved 17 February 2023. 
  31. 31.0 31.1 31.2 Lee, G.F. (10 October 2022). "The Robot May See You Now: It’s time to stop and think about the ethics of artificial intelligence". The Pathologist. https://thepathologist.com/outside-the-lab/the-robot-may-see-you-now. Retrieved 17 February 2023. 
  32. 32.0 32.1 32.2 Sherwood, L. (10 February 2022). "SLAS 2022: Barriers remain to AI adoption in life sciences". LabPulse.com Showcasts. Science and Medicine Group. https://www.labpulse.com/showcasts/slas/2022/article/15300130/slas-2022-barriers-remain-to-ai-adoption-in-life-sciences. Retrieved 17 February 2023. 
  33. 33.0 33.1 33.2 33.3 Bellini, Claudia; Padoan, Andrea; Carobene, Anna; Guerranti, Roberto (25 November 2022). "A survey on Artificial Intelligence and Big Data utilisation in Italian clinical laboratories" (in en). Clinical Chemistry and Laboratory Medicine (CCLM) 60 (12): 2017–2026. doi:10.1515/cclm-2022-0680. ISSN 1434-6621. https://www.degruyter.com/document/doi/10.1515/cclm-2022-0680/html. 
  34. Chada, Bharadwaj V; Summers, Leanne (10 October 2022). "AI in the NHS: a framework for adoption" (in en). Future Healthcare Journal: fhj.2022–0068. doi:10.7861/fhj.2022-0068. ISSN 2514-6645. PMC PMC9761451. PMID 36561823. https://www.rcpjournals.org/lookup/doi/10.7861/fhj.2022-0068.